Showing results (181-190 of 443) with videos related to

Sort By:
Pageof 45
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2Peter Attia, Daniel J Powell, Ajay V Maker, et al.
Molecular Cancer Therapeutics|October 8, 2015
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing TumorsRonit Mazor, Jingli Zhang, Laiman Xiang, et al.
European Journal of Haematology|September 7, 2007
Mesothelin, a possible target for immunotherapy, is expressed in primary AML cellsDaniel Steinbach, Masanori Onda, Astrid Voigt, et al.
Biochemical and Biophysical Research Communications|March 3, 2009
Non-AUG translational initiation of a short CAPC transcript generating protein isoformSuresh Anaganti, Johanna K Hansen, Duc Ha, et al.
Journal of the American Society of Nephrology : JASN|April 21, 2012
Liver angiotensinogen is the primary source of renal angiotensin IITaiji Matsusaka, Fumio Niimura, Akihiro Shimizu, et al.
American Journal of Physiology. Renal Physiology|February 13, 2015
Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injuryMasahiro Okabe, Yoichi Miyazaki, Fumio Niimura, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2011
Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopesMasanori Onda, Richard Beers, Laiman Xiang, et al.
American Journal of Physiology. Renal Physiology|October 25, 2013
The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosisKazuo Sakamoto, Toshiharu Ueno, Namiko Kobayashi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitisBenjamin Terrier, Satoshi Nagata, Tomoko Ise, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancersRaffit Hassan, Susie Bullock, Ahalya Premkumar, et al.
Pageof 45